NPPA issued the retail price of the Empagliflozin 12.5 mg + Metformin Hydrochloride IP 1000 mg (as extended release) for M/s Pure and Cure Healthcare Pvt. Ltd. (Manufacturer) and M/s Aristo Pharmaceuticals Pvt. Ltd (Marketer)

Feb 28, 2025 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on February 21, 2025, issued the retail price of the Empagliflozin 12.5 mg + Metformin Hydrochloride IP 1000 mg (as extended release) for M/s Pure and Cure Healthcare Pvt. Ltd. (Manufacturer) and M/s Aristo Pharmaceuticals Pvt. Ltd (Marketer).

The following have been stated:

• The retail price of Each Film Coated Bilayered Tablet Contains: Empagliflozin 12.5 mg + Metformin Hydrochloride IP 1000 mg (as extended release) for M/s Pure and Cure Healthcare Pvt. Ltd. (Manufacturer) and M/s Aristo Pharmaceuticals Pvt. Ltd (Marketer) will be Rs. 38.02/-.

• Sum of MAT value considered for price calculation (in Lakhs) - 3,347.73

• Sum of PTR per unit considered for price calculation - 98.34


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT